Veer Bhavnagri, General Counsel at Allogene Therapeutics, Inc. (ALLO), sold 23,246 shares at $38.16 ($884K) on 2021-03-15, disclosed to the SEC on 2021-03-17.
Open-market sale of $884k ALLO by General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.79 | 9,600 | $363K | 41.1% |
| 2 | $38.15 | 400 | $15K | 1.7% |
| 3 | $38.16 | 6,623 | $253K | 28.6% |
| 4 | $38.16 | 6,623 | $253K | 28.6% |
| Total | $38.01 avg | 23,246 | $884K | 100% |
| Filing → |
| ALLO | SELL | 2022-12-19 | $42K | — | Filing → |
| ALLO | SELL | 2022-03-17 | $136K | — | Filing → |
| ALLO | SELL | 2021-09-17 | $124K | — | Filing → |